Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners以買入評級開始對AcelRx Pharmicals進行報道，宣佈目標股價爲4.25美元
Alliance Global Partners analyst James Molloy initiates coverage on AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy rating and announces Price Target of $4.25.
Alliance Global Partners分析師詹姆斯·莫洛伊以買入評級開始報道AcelrX Pharmicals（納斯達克股票代碼：ACRX），並宣佈目標股價爲4.25美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。